glp-1-directed nmda receptor antagonism for obesity treatment Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Agonists | Advances in Therapy GLP-1 and NMDA Targeted Weight-Loss

Retatrutide adds glucagon receptor activation on top of that, producing the most significant weight loss of any peptide studied to date

Related reading on PlexusDx: GLP-1 What Is, GLP-1 Receptor Agonist, GLP-1 Drugs, GLP-1 Hormone

The dose escalates gradually based on tolerance and response

Super easy and attainable

A newer version of phentermine (combining phentermine with topiramate in one pill) was approved for chronic weight management in adults and kids down to age 12 in 2012 and marketed as Qsymia

If youd like help checking whether your plan covers these medications, or finding one that does, schedule your FREE call today